APEX Trial
Overview
The APEX Trial is a trial of the Factor Xa inhibitor betrixaban in the management of medically ill patients.
Investigators
Principal Investigators for the APEX Trial include the following:
The APEX Trial is a trial of the Factor Xa inhibitor betrixaban in the management of medically ill patients.
Principal Investigators for the APEX Trial include the following: